Skip to content

SION SION Exchange Offer (Note 12)

Exchange Offer (Note 12) at other companies

Macerich logo
MacerichMAC
$5.23M+4,335%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$52.83M
Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
$1.02M+687,316%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$1K
ServiceTitan, Inc. logo
ServiceTitan, Inc.TTAN
$348.97K
Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION
$0-100%

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.8B
Enterprise value$1.74B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:ConversionOfStockAmountConverted1.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's exchange offer (note 12).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's exchange offer (note 12)?
SION (SION) reported exchange offer (note 12) of $0 in Q1 2026.
How has SION's exchange offer (note 12) changed year-over-year?
SION's exchange offer (note 12) decreased by 100.0% year-over-year, from $330.37M to $0.
What does exchange offer (note 12) mean?
This represents the non-cash reclassification of preferred equity into common equity, typically occurring upon a liquidity event such as an initial public offering. It reflects the simplification of the company's capital structure as preferred shareholders exercise conversion rights. This metric is vital for investors to understand changes in ownership dilution and the transition to a standard common stock equity base.